Join
Live feed
·
INSIDERFilingvia Quantisnow
Artiva Biotherapeutics Inc. logo

SVP, Research and Development Raymon Heather was granted 33,350 shares, increasing direct ownership by 334% to 43,350 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ARTV· Artiva Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARTV (Artiva Biotherapeutics Inc.) and more on Quantisnow.